Concepedia

Graham Caygill

GC

Statistics

Publications

3

Citations

145

H-Index

3

Active since

2006

Affiliations

Clinical Trials New Zealand(Current)

Capital and Coast District Health Board

Victoria University of Wellington

University of Otago

GNS Science

Graham Caygill is an author at Clinical Trials New Zealand specializing in immunotherapy, dendritic cell biology, and immunology.

Publications per year

2006–2023

3

Publications

3

Scalable Reactor Design for Pharmaceuticals and Fine Chemicals Production. 1: Potential Scale-up Obstacles

Graham Caygill, M. Zanfir, Asterios Gavriilidis · Organic Process Research & Development · 2006 · 67 citations

Engineering, Chemical Engineering, Chemistry +15

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

Olivier Gasser, Katrina Sharples, Catherine Barrow et al. · Cancer Immunology Immunotherapy · 2017 · 58 citations · Full text

Medicine, Immunology, Oncology +16

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

Nathaniel Dasyam, Katrina Sharples, Catherine Barrow et al. · Cancer Immunology Immunotherapy · 2023 · 20 citations · Full text

Medicine, Immunology, Oncology +17

1–3 of 3